Position in DXCM
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$29,229
+$1,974 QoQ
Shares Held
434
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#787
of 966 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FINANCIAL CONSULATE, INC holds $407,360 across 17 Medical Devices names. DXCM ranks #3 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,523 | $228,937 | |
| 2 | SYK |
Stryker Corp
|
259 | $81,543 | |
| 3 | DXCM |
Dexcom Inc
This page
|
434 | $29,229 | |
| 4 | MDT |
Medtronic plc
|
171 | $13,377 | |
| 5 | BFLY |
Butterfly Network, Inc.
|
1,434 | $12,074 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
170 | $10,881 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
109 | $9,383 | |
| 8 | PHG |
Koninklijke Philips NV
|
282 | $7,667 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,229 | 434 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $27,255 | 434 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $29,202 | 440 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $28,934 | 430 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||